Ray Therapeutics

About Ray Therapeutics

Ray Therapeutics is a biotechnology company focused on developing bioengineered optogenetic medicines to restore vision for degenerative retinal diseases. The company uses optogenetics to reprogram surviving neurons in the retina to sense light and transmit visual signals to the brain, with programs aimed at restoring sight in conditions such as retinitis pigmentosa, choroideremia, Stargardt disease, and geographic atrophy. Its pipeline highlights multiple retinal disease indications and emphasizes science-led approaches to vision preservation and restoration. Headquartered in the United States, Ray Therapeutics positions itself at the intersection of neuroscience, ophthalmology, and gene-delivery-inspired therapies.